Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/15247
Title: Pharmaceutical equivalent dissertation of Metformin hydrochloride brands
Authors: Naveed, Safila
Dilshad, Huma
Nafees, Maheen
Shinwari, Muhammad Ibrar
Khan, Usman Ghani
Ghulam Sarwar
Keywords: Metformin
analysis and HPLC
Issue Date: 20-Jan-2018
Publisher: Karachi:Pakistan Journal of Pharmaceutical Sciences, University of Karachi
Citation: Naveed, S., Dilshad, H., Nafees, M., Shinwari, M. I., Usmanghani, K., & Sarwar, G. (2018). Pharmaceutical equivalent dissertation of Metformin hydrochloride brands. Pakistan Journal of Pharmaceutical Sciences, 31(1).
Abstract: The aim of study is to establish pharmaceutical equivalence of different brands of Metformin tablets available in Karachi, Pakistan. The quality control parameters which are studied are weight variation test, hardness test, thickness, friability, disintegration and dissolution specified by BP/USP (British and United State Pharmacopoeia). Weight variation and hardness value requirement was complied by all brands. Disintegration time for all brands was within range i.e. 15 minutes and also complies with the BP/USP recommendation. All brands showed more than 90% drug release within forty five minutes. The present conclusion suggests that almost all the brands of Metformin that are available in Karachi meet the specification for quality control analysis. Assay performed by HPLC by keeping flow rate of 1.0 ml/min of the mobile phase and the quantitative evaluation at 225 nm was performed. The retention time of Metformin was found to be 2.5min. Method suitability for the quantitative determination of the drugs was proved by validation according to the International Conference on Harmonization (ICH) guidelines.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/15247
ISSN: 1011-601X
Appears in Collections:Issue 01

Files in This Item:
File Description SizeFormat 
Paper-10.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.